The Hawthorne Collective to Invest $150 million in Canadian-based RIV Capital
TORONTO, May 12, 2021 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “ Company ” or " RAMM ") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical...
Palm Beach, FL – January 26, 2021 – In the recent years the use of CBD products have grown exponentially. They have become an everyday item in most people’ lives. In drug and food stores, you see...
Palm Beach, FL – January 22, 2021 – Revenue projections for the recreational and medical marijuana markets keep rising, each one larger than the previous studies. According to a recent report by...
RAGUSA, Italy, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Canapar Corp. (“Canapar”) and RAMM Pharma Corp. (including its wholly owned subsidiaries, "RAMM") (CSE: RAMM) are pleased to announce they have entered...
Canopy Rivers (TSX: RIV) (OTC: CNPOF), through its wholly owned subsidiary, Canopy Rivers Corporation, on Wednesday announced its entry into a definitive share purchase agreement. Under the agreement,...
TORONTO, Dec. 30, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical and...
Canopy Rivers (TSX: RIV) (OTC: CNPOF) , a venture capital firm specializing in cannabis, on Friday provided an update on its 49%-owned joint venture, PharmHouse Inc. Per the update, on Oct. 29, 2020, PharmHouse...
Canopy Rivers (TSX: RIV) (OTC: CNPOF) , a venture capital firm specializing in cannabis, on Thursday provided an update on three portfolio companies: TerrAscend, YSS and Dynaleo. “Over the past month,...
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today released its unaudited condensed interim consolidated financial statements and management’s discussion and...